Home Tempest Therapeutics

Tempest Therapeutics

In operation
Post-IPO Round
Tumor Immunotherapy Developer

Basic Information

Tempest Therapeutics is a clinical-stage biotechnology company dedicated to advancing small molecule therapies that modulate pathways of anti-tumor immunity. Tempest has a balanced and deep pipeline consisting of first-in-class small molecule therapies that regulate various immune response pathways associated with establishing effective anti-tumor responses.
Tempest Therapeutics Inc.
California,United States of America
15~50 people
January 01, 2011
partnering@tempesttx.com